Search Results - "Kuschak, T"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene by KUSCHAK, T. I, KUSCHAK, B. C, TAYLOR, C. L, WRIGHT, J. A, WIENER, F, MAI, S

    Published in Oncogene (31-01-2002)
    “…The mechanisms through which the oncoprotein c-Myc initiates locus-specific gene amplification are not understood. When analysing the initiation mechanism of…”
    Get full text
    Journal Article
  2. 2

    Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II by Hasinoff, Brian B., Kuschak, Theodore I., Creighton, Andrew M., Fattman, Cheryl L., Allan, William P., Thampatty, Padmakumari, Yalowich, Jack C.

    Published in Biochemical pharmacology (15-06-1997)
    “…A Chinese hamster ovary (CHO) cell line highly resistant to the non-cleavable complex-forming topoisomerase II inhibitor dexrazoxane (ICRF-187, Zinecard ®) was…”
    Get full text
    Journal Article
  3. 3

    Isolation of extrachromosomal elements by histone immunoprecipitation by Kuschak, T I, Kuschak, B C, Smith, G M, Wright, J A, Mai, S

    Published in BioTechniques (01-05-2001)
    “…Here, we describe a gentle and effective method for the rapid and reproducible isolation of histone-bound extrachromosomal DNA molecules called…”
    Get full text
    Journal Article
  4. 4

    A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane) by Hasinoff, Brian B., Kuschak, Theodore I., Yalowich, Jack C., Creighton, Andrew M.

    Published in Biochemical pharmacology (28-09-1995)
    “…A series of twelve structurally related bisdioxopiperazines that included ICRF-187 (dexrazoxane), ICRF-159 (razoxane), ICRF-193, and ICRF-154 were examined…”
    Get full text
    Journal Article
  5. 5

    c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene by Kuschak, TI, Kuschak, B C, Taylor, CL, Wright, JA, Wiener, F, Mai, S

    Published in Oncogene (31-01-2002)
    “…The mechanisms through which the oncoprotein c-Myc initiates locus-specific gene amplification are not understood. When analysing the initiation mechanism of…”
    Get full text
    Journal Article
  6. 6

    Metabolism of the cardioprotective agents dexrazoxane (ICRF-187) and levrazoxane (ICRF-186) by the isolated hepatocyte by Hasinoff, B B, Venkataram, S, Singh, M, Kuschak, T I

    Published in Xenobiotica (1994)
    “…1. The metabolism of dexrazoxane (ICRF-187) and its optical isomer levrazoxane (ICRF-186) by the isolated rat hepatocyte was studied by hplc. 2…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Deregulated Expression of c-Myc in a Translocation-Negative Plasmacytoma on Extrachromosomal Elements That Carry IgH and Myc Genes by Wiener, Francis, Kuschak, Theodore I., Ohno, Shinsuke, Mai, Sabine

    “…The induced expression of c-Myc in plasmacytomas in BALB/c mice is regularly associated with nonrandom chromosomal translocations that juxtapose the c-myc gene…”
    Get full text
    Journal Article
  9. 9

    Chromosomal and Extrachromosomal Instability of the cyclin D2 Gene is Induced by Myc Overexpression by Mai, Sabine, Hanley-Hyde, Joan, Rainey, G. Jonah, Kuschak, Theodore I., Paul, James T., Littlewood, Trevor D., Mischak, Harald, Stevens, Lisa M., Henderson, Darren W., Mushinski, J. Frederic

    Published in Neoplasia (New York, N.Y.) (01-08-1999)
    “…We examined the expression of cyclins D1, D2, D3, and E in mouse B-lymphocytic tumors. Cyclin D2 mRNA was consistently elevated in plasmacytomas, which…”
    Get full text
    Journal Article
  10. 10

    The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability by Kuschak, Theodore I., Taylor, Cheryl, McMillan-Ward, Eileen, Israels, Sara, Henderson, Darren W., Mushinski, J.Frederic, Wright, Jim A., Mai, Sabine

    Published in Gene (01-10-1999)
    “…The c-Myc oncoprotein is highly expressed in malignant cells of many cell types, but the mechanism by which it contributes to the transformation process is not…”
    Get full text
    Journal Article
  11. 11

    The one-ring open hydrolysis intermediates of the cardioprotective agent dexrazoxane (ICRF-187) do not inhibit the growth of Chinese hamster ovary cells or the catalytic activity of DNA topoisomerase II by Hasinoff, B B, Kuschak, T I, Fattman, C L, Yalowich, J C

    Published in Anti-cancer drugs (01-06-1998)
    “…Dexrazoxane (ICRF-187), which is clinically used to reduce doxorubicin-induced cardiotoxicity, has growth inhibitory properties through its ability to inhibit…”
    Get more information
    Journal Article
  12. 12

    Household transmission of SARS, 2003 by Wilson-Clark, Samantha D, Deeks, Shelley L, Gournis, Effie, Hay, Karen, Bondy, Susan, Kennedy, Erin, Johnson, Ian, Rea, Elizabeth, Kuschak, Theodore, Green, Diane, Abbas, Zahid, Guarda, Brenda

    “…In the 2003 outbreak in Toronto (in Ontario, Canada) of severe acute respiratory syndrome (SARS), about 20% of cases resulted from household transmission. The…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3 by Amara, F M, Smith, G M, Kuschak, T I, Takeuchi, T L, Wright, J A

    “…The R2 component of ribonucleotide reductase is rate-limiting for DNA synthesis in proliferating cells, and recently, it has been shown that aberrant…”
    Get full text
    Journal Article
  16. 16

    Transforming growth factor-beta1 stimulates multiple protein interactions at a unique cis-element in the 3'-untranslated region of the hyaluronan receptor RHAMM mRNA by Amara, F M, Entwistle, J, Kuschak, T I, Turley, E A, Wright, J A

    Published in The Journal of biological chemistry (21-06-1996)
    “…The receptor for hyaluronan mediated motility (RHAMM) gene expression is markedly elevated in fibrosarcomas exposed to transforming growth factor-beta1…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Transforming growth factor- beta sub(1) stimulates multiple protein interactions at a unique cis-element in the 3'-untranslated region of the hyaluronan receptor RHAMM mRNA by Amara, F M, Entwistle, J, Kuschak, TI, Turley, E A, Wright, JA

    Published in The Journal of biological chemistry (01-01-1996)
    “…The receptor for hyaluronan mediated motility (RHAMM) gene expression is markedly elevated in fibrosarcomas exposed to transforming growth factor- beta sub(1)…”
    Get full text
    Journal Article